Tumoral accumulation of long-circulating, self-assembled nanoparticles and its visualization by gamma scintigraphy

Authors
Cho, Yong WooKim, Yoo-ShinYjm, In-SanPark, Rang-WoonOh, Seung JunMoon, Dae HyukKim, Sang YoonKwon, Ick Chan
Issue Date
2008-01
Publisher
POLYMER SOC KOREA
Citation
MACROMOLECULAR RESEARCH, v.16, no.1, pp.15 - 20
Abstract
The enhanced permeability and retention (EPR) effect is used extensively for the passive targeting of many macromolecular drugs for tumors. Indeed, the EPR concept has been a gold standard in polymeric anticancer drug delivery systems. This study investigated the tumoral distribution of self-assembled nanoparticles based on the EPR effect using fluorescein and radio-labeled nanoparticles. Self-assembled nanoparticles were prepared from amphiphilic chitosan derivatives, and their tissue distribution was examined in tumor-bearing mice. The size of the nanoparticles was controlled to be 330 run, which is a size suited for opening between the defective endothelial cells in tumors. The long-circulating polymer nanoparticles were allowed to gradually accumulate in the tumors for 11 days. The amount of nanoparticles accumulated in the tumors was remarkably augmented from 3.4%ID/g tissue at 1 day to 25.9%ID/g tissue at 11 days after i.v. administration. The self-assembled nanoparticles were sustained at a high level throughout the 14 day experimental period, indicating their long systemic retention in the blood circulation. The gamma-images provided clear evidence of selective tumor localization of the I-131-labeled nanoparticles. Confocal microscopy revealed the fluorescein-labeled nanoparticles to be preferentially localized in the perivascular regions, suggesting their extravasation to the tumors through the hyperpermeable angiogenic tumor vasculature. This highly selective tumoral accumulation of nanoparticles was attributed to the leakiness of the blood vessels in the tumors and their long residence time in the blood circulation.
Keywords
MACROMOLECULAR THERAPEUTICS; VASCULAR-PERMEABILITY; SOLID TUMORS; DOXORUBICIN; BIODISTRIBUTION; ENHANCEMENT; MECHANISMS; ADVANTAGES; COPOLYMER; TRANSPORT; MACROMOLECULAR THERAPEUTICS; VASCULAR-PERMEABILITY; SOLID TUMORS; DOXORUBICIN; BIODISTRIBUTION; ENHANCEMENT; MECHANISMS; ADVANTAGES; COPOLYMER; TRANSPORT; nanoparticles; EPR effect; tumor targeting; long-circulating; gamma scintigraphy
ISSN
1598-5032
URI
https://pubs.kist.re.kr/handle/201004/133850
DOI
10.1007/BF03218955
Appears in Collections:
KIST Article > 2008
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE